- Home
- FSLR vs DXCM Comparison
FSLR vs DXCM Comparison
Compare FSLR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSLR | DXCM |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2B | 25.9B |
| IPO Year | 2006 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FSLR | DXCM |
|---|---|---|
| Price | $235.00 | $73.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 25 | 22 |
| Target Price | ★ $252.35 | $86.41 |
| AVG Volume (30 Days) | 2.1M | ★ 5.5M |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.25 | 7.75 |
| EPS | ★ 13.03 | 1.80 |
| Revenue | ★ $5,050,625,000.00 | $4,515,900,000.00 |
| Revenue This Year | $23.81 | $17.41 |
| Revenue Next Year | $20.64 | $12.73 |
| P/E Ratio | ★ $18.65 | $40.82 |
| Revenue Growth | ★ 31.16 | 14.21 |
| 52 Week Low | $116.56 | $54.11 |
| 52 Week High | $285.99 | $93.25 |
Technical Indicators
Market Signals| Indicator | FSLR | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 66.67 |
| Support Level | $237.92 | $68.54 |
| Resistance Level | $249.50 | $74.01 |
| Average True Range (ATR) | 10.57 | 2.62 |
| MACD | -0.83 | 0.32 |
| Stochastic Oscillator | 7.59 | 77.16 |
Price Performance
Historical ComparisonAbout FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.